127 related articles for article (PubMed ID: 34118837)
41. Prognostic values of Ki-67 in neoadjuvant setting for breast cancer: a systematic review and meta-analysis.
Li L; Han D; Wang X; Wang Q; Tian J; Yao J; Yuan L; Qian K; Zou Q; Yi W; Zhou E; Yang K
Future Oncol; 2017 May; 13(11):1021-1034. PubMed ID: 28088868
[TBL] [Abstract][Full Text] [Related]
42. The Prognostic Value of a Pathologic Complete Response After Neoadjuvant Therapy for Digestive Cancer: Systematic Review and Meta-Analysis of 21 Studies.
Wan T; Zhang XF; Liang C; Liao CW; Li JY; Zhou YM
Ann Surg Oncol; 2019 May; 26(5):1412-1420. PubMed ID: 30805807
[TBL] [Abstract][Full Text] [Related]
43. RECIST 1.1 criteria predict recurrence-free survival in advanced ovarian cancer submitted to neoadjuvant chemotherapy.
Bogani G; Matteucci L; Tamberi S; Ditto A; Sabatucci I; Murgia F; Arcangeli V; Maltese G; Comerci G; Stefanetti M; Sonetto C; Calareso G; Marchiano A; Chiappa V; Lorusso D; Raspagliesi F
Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():93-99. PubMed ID: 31029972
[TBL] [Abstract][Full Text] [Related]
44. The relation of passive smoking with cervical cancer: A systematic review and meta-analysis.
Su B; Qin W; Xue F; Wei X; Guan Q; Jiang W; Wang S; Xu M; Yu S
Medicine (Baltimore); 2018 Nov; 97(46):e13061. PubMed ID: 30431576
[TBL] [Abstract][Full Text] [Related]
45. Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: a systematic review and meta-analysis.
Xu Y; Zhang Y; Wang X; Kang J; Liu X
BMC Cancer; 2019 Feb; 19(1):168. PubMed ID: 30795756
[TBL] [Abstract][Full Text] [Related]
46. Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients.
Kong X; Moran MS; Zhang N; Haffty B; Yang Q
Eur J Cancer; 2011 Sep; 47(14):2084-90. PubMed ID: 21737257
[TBL] [Abstract][Full Text] [Related]
47. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
[TBL] [Abstract][Full Text] [Related]
48. Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer.
Li J; Wu MF; Lu HW; Chen Q; Lin ZQ; Wang LJ
Cancer Med; 2016 Aug; 5(8):1863-72. PubMed ID: 27350066
[TBL] [Abstract][Full Text] [Related]
49. The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics.
Shao C; Dai W; Li H; Tang W; Jia S; Wu X; Luo Y
PLoS One; 2017; 12(2):e0171676. PubMed ID: 28207831
[TBL] [Abstract][Full Text] [Related]
50. Impact of Blood Transfusions on Survival of Locally Advanced Cervical Cancer Patients Undergoing Neoadjuvant Chemotherapy Plus Radical Surgery.
Bogani G; Ditto A; Martinelli F; Signorelli M; Chiappa V; Lopez C; Indini A; Leone Roberti Maggiore U; Sabatucci I; Lorusso D; Raspagliesi F
Int J Gynecol Cancer; 2017 Mar; 27(3):514-522. PubMed ID: 28129238
[TBL] [Abstract][Full Text] [Related]
51. Optimal pathological response indicated better long-term outcome among patients with stage IB2 to IIB cervical cancer submitted to neoadjuvant chemotherapy.
Huang K; Sun H; Chen Z; Li X; Wang S; Zhao X; Tang F; Jia Y; Hu T; Du X; Wang H; Lu Z; Huang J; Gui J; Wang X; Zhou S; Wang L; Zhang J; Guo L; Yang R; Shen J; Zhang Q; Li S; Wang S
Sci Rep; 2016 Jun; 6():28278. PubMed ID: 27325186
[TBL] [Abstract][Full Text] [Related]
52. Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.
Gadducci A; Landoni F; Cosio S; Zizioli V; Zola P; Ferrero AM; Lapresa MT; Maggino T; Sartori E
Anticancer Res; 2018 Jun; 38(6):3627-3634. PubMed ID: 29848719
[TBL] [Abstract][Full Text] [Related]
53. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
54. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
Yin M; Zhang H; Li H; Li X; Liu Y; Chen X; Lou G; Li K
J Surg Oncol; 2012 Feb; 105(2):206-11. PubMed ID: 21815150
[TBL] [Abstract][Full Text] [Related]
55. [Analysis of effects and postoperative clinicopathological prognosis factors of neoadjuvant chemotherapy in patients with stage Ⅰb2 and Ⅱa2 squamous cell carcinoma of the cervix].
An JS; Zhao YX; Song Y; Li N; Huang MN; Li XG; Li B; Zhang R; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Oct; 54(10):673-679. PubMed ID: 31648443
[No Abstract] [Full Text] [Related]
56. Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy.
Leow JJ; Chong YL; Chang SL; Valderrama BP; Powles T; Bellmunt J
Eur Urol; 2021 May; 79(5):635-654. PubMed ID: 32798146
[TBL] [Abstract][Full Text] [Related]
57. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
58. Prognostic value of stromal decorin expression in patients with breast cancer: a meta-analysis.
Li SJ; Chen DL; Zhang WB; Shen C; Che GW
J Thorac Dis; 2015 Nov; 7(11):1939-50. PubMed ID: 26716032
[TBL] [Abstract][Full Text] [Related]
59. Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer.
Li J; Wu MF; Lu HW; Zhang BZ; Wang LJ; Lin ZQ
PLoS One; 2016; 11(11):e0166612. PubMed ID: 27851819
[TBL] [Abstract][Full Text] [Related]
60. Survival outcome and perioperative complication related to neoadjuvant chemotherapy with carboplatin and paclitaxel for advanced ovarian cancer: A systematic review and meta-analysis.
Machida H; Tokunaga H; Matsuo K; Matsumura N; Kobayashi Y; Tabata T; Kaneuchi M; Nagase S; Mikami M
Eur J Surg Oncol; 2020 May; 46(5):868-875. PubMed ID: 31818526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
